Compare Becton Dickinson and Co (BDX) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Zillow Group Inc Class A — how do they compare? Becton Dickinson and Co trades at $155 (market cap $41.51B), while Zillow Group Inc Class A trades at $33.8 (market cap $7.28B). The key difference: Becton Dickinson and Co is far larger — about 5.7× Zillow Group Inc Class A's market cap, and Becton Dickinson and Co pays a 2.79% dividend while Zillow Group Inc Class A pays none. Which is the better fit depends on your goals.
| BDX | ZG | |
|---|---|---|
Market Cap | $41.51B | $7.28B |
Sector | Health | Media |
52-Week High | $185.39 | $86.76 |
52-Week Low | $135.49 | $29.14 |
Enterprise Value | $57.97B | $6.93B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Zillow Group (ZG) trades at $31.94, down 0.19% with a bearish technical signal. The company shows improving fundamentals with revenue growth to $2.58B in 2025 and a return to profitability with $23M net income. Analyst consensus remains positive with a $57.80 price target, though recent securities class action lawsuits create near-term uncertainty. Technical indicators show the stock trading near support at $31 with resistance at $33.
ZG presents a mixed outlook with strong analyst support but significant legal overhangs. The company's turnaround to profitability and 51% buy rating suggest upside potential, but ongoing litigation regarding anticompetitive practices with Redfin poses substantial risk. Investors should weigh improving fundamentals against regulatory and legal challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
